IHS Chemical Week

Regions :: Western Europe :: Switzerland

Lonza Forms Alliance and Acquires Stake in U.S. Drug Discovery Tech Firm

2:57 AM MST | March 9, 2010 |

Deepti Ramesh

Lonza says it has signed an agreement with drug discovery technology company Odyssey Thera (San Ramon, CA) to make Odyssey Thera’s proprietary protein-fragment complementation assay (PCA) technology, and Odyssey Thera has granted to Lonza an option to certain exclusive global technology licenses. Lonza has made an equity investment in Odyssey Thera, and has become a minority shareholder in the company. Odyssey Thera, under the terms of the agreement, is eligible to receive technology development funding, milestones and royalties on Lonza product and service...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa